FedEx Corporation vs Mesoblast Limited — how do they compare? FedEx Corporation trades at $322.99 (market cap $76.28B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: FedEx Corporation is far larger — about 34.5× Mesoblast Limited's market cap, and FedEx Corporation pays a 1.51% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| FDX | MESO | |
|---|---|---|
Market Cap | $76.28B | $2.21B |
Sector | Industrials | Technology |
52-Week High | $338.75 | $20.96 |
52-Week Low | $180.51 | $12.88 |
Enterprise Value | $105.91B | $2.21B |
Dividend Yield | 1.51% | — |
Trailing returns across standard periods
FedEx pioneered overnight delivery in 1973 and remains the world's largest express package provider. In its fiscal 2020 (ended May 2020), FedEx derived 51% of revenue from its express division, 33% from ground, and 10% from freight, its asset-based less-than-truckload shipping segment. The remainder comes from other services, including FedEx Office, which provides document production/shipping, and FedEx Logistics, which provides global forwarding. FedEx acquired Dutch parcel delivery firm TNT Express in 2016. TNT was previously the fourth-largest global parcel delivery provider.
Read more on FDX →Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →